Author

Roy Kishony

Technion – Israel Institute of TechnologyORCID 0000-0002-5013-5072Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Roy Kishony2 papers

Biology Disciplines

Click to filter author papers

Microbiology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:bacteria (other)· 1 Research Focus:benchmarking· 1 Organism:E. coli· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

Adrian Veres· 1 shared Dor RussiD· 1 shared Michael BaymiD· 1 shared Yunxin J. JiaoiD· 1 shared

Activity by Year

2016-2018 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Adrian Veres

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The null additivity of multi-drug combinations

Dor Russ, Roy Kishony

The paper compares two models for predicting drug combination effects in E. coli and finds Bliss additivity outperforms Loewe as more drugs are added.

Nature Microbiology · Oct 3, 2018Peer-reviewedSystems Biology

Population diversity jeopardizes the efficacy of antibiotic cycling

Yunxin J. Jiao, Michael Baym, Adrian Veres, Roy Kishony

This study shows that population diversity can reduce the effectiveness of antibiotic cycling strategies by enabling rare positive cross-resistant mutants to emerge.

bioRxiv · Oct 20, 2016 · PreprintMicrobiology